跳至主要内容
临床试验/TCTR20220921002
TCTR20220921002招募中不适用

Assessment of lymphoma involvement in bone marrow by a novel cell-based liquid biopsy platform from blood sampling

Siriraj Hospital Mahidol University0 个研究点目标入组 176 人开始时间: 2022年9月21日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
176

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • 1. Newly diagnosed lymphoma of any subtypes
  • 2. Aged greater than 18 years
  • 3. Participants with normal white blood cell (WBC) counts and normal differential WBC counts from the last CBC result (within 1 year)

排除标准

  • 1. Participants with known underlying diseases of hemolytic anemia
  • 2. Participants with known underlying diseases of hematologic malignancy besides lymphoma
  • 3. Participants with known underlying disease of neoplasms involving bone marrow
  • 4. Participants with lymphocytosis (absolute lymphocyte count > 4,000/mcL)
  • 5. Participants with a history of recently receiving blood transfusion within 4 weeks
  • 6. Participants with a history of receiving chemotherapy within 4 weeks
  • 7. Participants with a history of blood donation or recent blood loss greater than 250 mL within 4 weeks
  • 8. Participants who receiving erythropoietin
  • 9. Participants with GI mucosal involvement of lymphoma

研究者

发起方
Siriraj Hospital Mahidol University

相似试验

Assessment of lymphoma involvement in bone marrow by... | 临床试验